Virginie joined Anaveon in April 2023 as Clinical Trial Leader. She has more than ten years of experience in clinical trials, including data management and IRT, gained at CROs and pharmaceutical companies. Previously, she worked at Novartis as a Trial Manager in Global Drug Development on a Phase I/II study in haematology and in Global Medical Affairs on Phase II and III studies in solid tumours.
Virginie holds a Master’s degree in Chemistry from the Ecole Nationale Supérieure de Chimie de Lille (France) and a PhD in Organic Chemistry from the University of Toledo (USA).
